SEC
|
Perkins Adelene Q
|
N/A
|
|
-410K
|
$0.07
|
-$28.71K
|
|
SEC
|
Peluso Stephane
|
Chief Scientific Officer
|
|
+65K
|
$0.66
|
+$42.90K
|
|
SEC
|
EVNIN ANTHONY B
|
N/A
|
|
+46K
|
$0.68
|
+$31.54K
|
|
SEC
|
SCHWARTZ BRIAN
|
N/A
|
|
+31K
|
$0.68
|
+$21.02K
|
|
SEC
|
BEIER DAVID W
|
N/A
|
|
+3.1K
|
$3.43
|
+$10.50K
|
|
SEC
|
EVNIN ANTHONY B
|
N/A
|
|
+3.1K
|
$3.43
|
+$10.50K
|
|
SEC
|
SELBY NORMAN C
|
N/A
|
|
+5K
|
$0.92
|
+$4.60K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
-2.3M
|
$5.37
|
-$12.14M
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
-5.8M
|
$4.14
|
-$24.21M
|
|
SEC
|
Berkowitz Jeffrey
|
N/A
|
|
+26K
|
$1.60
|
+$42.00K
|
|
SEC
|
EVNIN ANTHONY B
|
N/A
|
|
+13K
|
$1.60
|
+$21.00K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+175K
|
$1.20
|
+$210.00K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+100K
|
$1.30
|
+$130.00K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+1.5M
|
$1.37
|
+$2.01M
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+906K
|
$1.35
|
+$1.22M
|
|
SEC
|
Perkins Adelene Q
|
Chief Executive Officer
|
|
-5K
|
$2.82
|
-$14.10K
|
|
SEC
|
Kutok Jeffery
|
Chief Scientific Officer
|
|
-14K
|
$2.00
|
-$28.63K
|
|
SEC
|
Kutok Jeffery
|
Chief Scientific Officer
|
|
-14K
|
$2.00
|
-$28.63K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+3.9M
|
$1.65
|
+$6.50M
|
|
SEC
|
BEIER DAVID W
|
N/A
|
|
+5.7K
|
$1.75
|
+$10.00K
|
|
SEC
|
Berkowitz Jeffrey
|
N/A
|
|
+23K
|
$1.75
|
+$40.00K
|
|
SEC
|
EVNIN ANTHONY B
|
N/A
|
|
+11K
|
$1.75
|
+$20.00K
|
|
SEC
|
SMITH IAN F
|
N/A
|
|
+23K
|
$1.75
|
+$40.00K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+1.5M
|
$1.97
|
+$2.97M
|
|
SEC
|
Perkins Adelene Q
|
Chief Executive Officer
|
|
-5K
|
$2.78
|
-$13.90K
|
|
SEC
|
BLOCH LAWRENCE E
|
President
|
|
+500K
|
$1.81
|
+$905.00K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+1.6M
|
$1.26
|
+$2.02M
|
|
SEC
|
Berkowitz Jeffrey
|
N/A
|
|
+5.7K
|
$1.74
|
+$10.00K
|
|
SEC
|
EVNIN ANTHONY B
|
N/A
|
|
+11K
|
$1.74
|
+$20.00K
|
|
SEC
|
SMITH IAN F
|
N/A
|
|
+23K
|
$1.74
|
+$40.00K
|
|
SEC
|
VENUTI MICHAEL C
|
N/A
|
|
-6.3K
|
$3.48
|
-$21.75K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+4.4K
|
$1.34
|
+$5.87K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+742K
|
$1.34
|
+$994.82K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+655K
|
$1.31
|
+$857.95K
|
|
SEC
|
KANGO SUJAY
|
Chief Commercial Officer
|
|
-75K
|
$1.28
|
-$96.00K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+201K
|
$1.19
|
+$239.66K
|
|
SEC
|
Perkins Adelene Q
|
President & CEO
|
|
-5K
|
$10.93
|
-$54.65K
|
|
SEC
|
Palombella Vito J.
|
Chief Scientific Officer
|
|
-4.7K
|
$10.97
|
-$51.96K
|
|
SEC
|
Perkins Adelene Q
|
President & CEO
|
|
-10K
|
$12.81
|
-$128.10K
|
|
SEC
|
Perkins Adelene Q
|
President & CEO
|
|
-10K
|
$12.18
|
-$121.80K
|
|
SEC
|
Perkins Adelene Q
|
President & CEO
|
|
-20K
|
$16.00
|
-$320.00K
|
|
SEC
|
Perkins Adelene Q
|
President & CEO
|
|
-25K
|
$16.50
|
-$412.50K
|
|
SEC
|
Perkins Adelene Q
|
President & CEO
|
|
-20K
|
$14.83
|
-$296.60K
|
|
SEC
|
Palombella Vito J.
|
Chief Scientific Officer
|
|
-4.7K
|
$16.32
|
-$77.31K
|
|
SEC
|
Palombella Vito J.
|
Chief Scientific Officer
|
|
-4.7K
|
$15.00
|
-$71.04K
|
|
SEC
|
EVNIN ANTHONY B
|
N/A
|
|
-112K
|
$13.56
|
-$1.52M
|
|
SEC
|
Palombella Vito J.
|
Chief Scientific Officer
|
|
-9.5K
|
$15.39
|
-$145.77K
|
|
SEC
|
Palombella Vito J.
|
Chief Scientific Officer
|
|
-879
|
$12.87
|
-$11.31K
|
|
SEC
|
Palombella Vito J.
|
Chief Scientific Officer
|
|
-4.7K
|
$15.00
|
-$71.04K
|
|
SEC
|
Palombella Vito J.
|
Chief Scientific Officer
|
|
-753
|
$13.52
|
-$10.18K
|
|
SEC
|
EVNIN ANTHONY B
|
N/A
|
|
-18K
|
$14.56
|
-$258.53K
|
|
SEC
|
EVNIN ANTHONY B
|
N/A
|
|
-164K
|
$14.82
|
-$2.43M
|
|
SEC
|
Perkins Adelene Q
|
Pres & Chief Executive Officer
|
|
-45K
|
$20.72
|
-$932.40K
|
|
SEC
|
Palombella Vito J.
|
Chief Scientific Officer
|
|
-23K
|
$18.53
|
-$428.97K
|
|
SEC
|
Beacon Co
|
N/A
|
|
-5.7M
|
$38.40
|
-$219.20M
|
|
SEC
|
Rosebay Medical Co L.P.
|
N/A
|
|
-5.7M
|
$38.40
|
-$219.20M
|
|
SEC
|
EVNIN ANTHONY B
|
N/A
|
|
-22K
|
$25.14
|
-$565.15K
|
|
SEC
|
Lindblom Christopher M
|
See Remarks
|
|
-14K
|
$25.73
|
-$357.26K
|
|
SEC
|
Beacon Co
|
N/A
|
|
+5.4M
|
$14.50
|
+$78.54M
|
|
SEC
|
Rosebay Medical Co L.P.
|
N/A
|
|
+5.4M
|
$14.50
|
+$78.54M
|
|
SEC
|
Holtzman Steven H
|
N/A
|
|
-58K
|
$13.01
|
-$749.02K
|
|
SEC
|
Holtzman Steven H
|
N/A
|
|
-200K
|
$13.00
|
-$2.60M
|
|
SEC
|
Perkins Adelene Q
|
Pres & Chief Executive Officer
|
|
+25K
|
$6.10
|
+$152.50K
|
|
SEC
|
Perkins Adelene Q
|
Pres & Chief Executive Officer
|
|
+50K
|
$4.90
|
+$245.00K
|
|
SEC
|
Beacon Co
|
N/A
|
|
+1M
|
$15.00
|
+$15.00M
|
|
SEC
|
Rosebay Medical Co L.P.
|
N/A
|
|
+1M
|
$15.00
|
+$15.00M
|
|
SEC
|
Perkins Adelene Q
|
Pres & Chief Business Officer
|
|
+9.2K
|
$7.90
|
+$72.68K
|
|
SEC
|
Perkins Adelene Q
|
Pres & Chief Business Officer
|
|
+22K
|
$6.16
|
+$135.77K
|
|
SEC
|
Holtzman Steven H
|
President and CEO
|
|
+22K
|
$7.40
|
+$163.56K
|
|
SEC
|
Perkins Adelene Q
|
EVP and Chief Business Officer
|
|
+776
|
$5.91
|
+$4.59K
|
|
SEC
|
Holtzman Steven H
|
Chairman and CEO
|
|
+5K
|
$9.12
|
+$45.60K
|
|
SEC
|
Perkins Adelene Q
|
EVP and Chief Business Officer
|
|
+10K
|
$10.64
|
+$106.40K
|
|
SEC
|
Perkins Adelene Q
|
EVP and Chief Business Officer
|
|
+6.4K
|
$10.86
|
+$70.00K
|
|
SEC
|
Perkins Adelene Q
|
EVP and Chief Business Officer
|
|
+3.1K
|
$11.03
|
+$33.66K
|
|